Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.
Menssouri N, Poiraudeau L, Helissey C, Bigot L, Sabio J, Ibrahim T, Pobel C, Nicotra C, Ngo-Camus M, Lacroix L, Rouleau E, Tselikas L, Chauchereau A, Blanc-Durand F, Bernard-Tessier A, Patrikidou A, Naoun N, Flippot R, Colomba E, Fuerea A, Albiges L, Lavaud P, van de Wiel P, den Biezen E, Wesseling-Rozendaal Y, Ponce S, Michiels S, Massard C, Gautheret D, Barlesi F, André F, Besse B, Scoazec JY, Friboulet L, Fizazi K, Loriot Y. Menssouri N, et al. Among authors: flippot r. Clin Cancer Res. 2023 Nov 1;29(21):4504-4517. doi: 10.1158/1078-0432.CCR-22-3736. Clin Cancer Res. 2023. PMID: 37364000
[Nivolumab, a new hope in non-small cell lung cancer].
Flippot R, Fallet V, Besse B, Massard C, Wislez M, Vignot S. Flippot R, et al. Bull Cancer. 2015 Dec;102(12):1046-52. doi: 10.1016/j.bulcan.2015.10.005. Epub 2015 Nov 14. Bull Cancer. 2015. PMID: 26585939 Review. French.
Non-Clear Cell Renal Cell Carcinomas: From Shadow to Light.
Albiges L, Flippot R, Rioux-Leclercq N, Choueiri TK. Albiges L, et al. Among authors: flippot r. J Clin Oncol. 2018 Oct 29:JCO2018792531. doi: 10.1200/JCO.2018.79.2531. Online ahead of print. J Clin Oncol. 2018. PMID: 30372389 Review.
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases.
Flippot R, Biondani P, Auclin E, Xiao D, Hendriks L, Le Rhun E, Leduc C, Beau-Faller M, Gervais R, Remon J, Adam J, Planchard D, Lavaud P, Naltet C, Caramella C, Le Pechoux C, Lacroix L, Gazzah A, Mezquita L, Besse B. Flippot R, et al. J Thorac Oncol. 2019 Aug;14(8):1400-1407. doi: 10.1016/j.jtho.2019.05.007. Epub 2019 May 18. J Thorac Oncol. 2019. PMID: 31108248 Free article.
Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma.
Guida A, Le Teuff G, Alves C, Colomba E, Di Nunno V, Derosa L, Flippot R, Escudier B, Albiges L. Guida A, et al. Among authors: flippot r. Oncotarget. 2020 Dec 8;11(49):4582-4592. doi: 10.18632/oncotarget.27762. eCollection 2020 Dec 8. Oncotarget. 2020. PMID: 33346231 Free PMC article.
67 results